Brief: Compugen Doses First Patient In Com701 Phase 1 Monotherapy Expansion Cohort
27/05/2020 14:25
May 27 (Reuters) - Compugen Ltd CGEN.TA :
* COMPUGEN DOSES FIRST PATIENT IN COM701 PHASE 1 MONOTHERAPY
EXPANSION COHORT
* COMPUGEN LTD - INITIAL DATA FROM CLINICAL TRIAL OF COM701
EXPECTED IN H1 2021
Source text for Eikon: ID:nPn3rzDzta
Further company coverage: CGEN.TA
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Compugen
See all newsIsrael's Compugen Q2 revenue more than doubles, net loss narrows
Brief: Compugen Announces The Appointment Of Michele Holcomb, Ph.D., To Its Board Of Directors
Brief: Compugen Monetizes Portion Of Rilvegostomig Future Royalties To Astrazeneca For Up To $90 Million
Brief: Compugen Announces First Patient Dosed In Com701 Global Platform Trial In Platinum Sensitive Ovarian Cancer
Brief: Compugen Announces Leadership Transitions Effective September 2025